Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
| Catalog No. | Product Name | Size | List Price (US$) | Quantity |
|---|
Conditions of optimal recombinant FITC-Compatible Human BCMA/TNFRSF17 Protein performance should be determined experimentally by the investigator.
Price/availability/specifications subject to change without notice. Unless otherwise indicated, our catalog and customized products are for research use only and not intended for human or animal diagnostic or therapeutic use.
Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
BP003385: FITC-Compatible Human BCMA/TNFRSF17 Protein with the C-His Tag
Source: The recombinant FITC-Compatible Human BCMA/TNFRSF17 Protein, (amino acids Met1-Ala54) fused with a His tag at the C-terminus, was produced in HEK 293 cells.
Molecular Weight:The recombinant FITC-Compatible Human BCMA/TNFRSF17 protein with the His tag at the C-terminus has a predicted MW of 35.9 kDa. Due to glycosylation, the protein migrates to 37-48 kDa based on Tris-Bis PAGE result.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.
Formulation: Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution: It is recommended to reconstitute the lyophilized recombinant FITC-Compatible Human BCMA/TNFRSF17 Protein in sterile H2O to a protein concentration not less than 100 ug/ml. Centrifuge the tube before opening.
Copyright © 2009-2022 sydlabs.com. All rights reserved.
Use of this website means that you have read, understood, and accepted the Syd Labs Privacy Policy and Terms & Conditions.